503 related articles for article (PubMed ID: 26818702)
1. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of Ru(II) piano-stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA.
Colina-Vegas L; Villarreal W; Navarro M; de Oliveira CR; Graminha AE; Maia PIDS; Deflon VM; Ferreira AG; Cominetti MR; Batista AA
J Inorg Biochem; 2015 Dec; 153():150-161. PubMed ID: 26277415
[TBL] [Abstract][Full Text] [Related]
3. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
[TBL] [Abstract][Full Text] [Related]
4. [(η(6)-p-cymene)Ru(H2O)3](2+) binding capability of aminohydroxamates - A solution and solid state study.
Parajdi-Losonczi PL; Bényei AC; Kováts É; Timári I; Muchova TR; Novohradsky V; Kasparkova J; Buglyó P
J Inorg Biochem; 2016 Jul; 160():236-45. PubMed ID: 26971623
[TBL] [Abstract][Full Text] [Related]
5. Anticancer activity and DNA binding of a bifunctional Ru(II) arene aqua-complex with the 2,4-diamino-6-(2-pyridyl)-1,3,5-triazine ligand.
Busto N; Valladolid J; Martínez-Alonso M; Lozano HJ; Jalón FA; Manzano BR; Rodríguez AM; Carrión MC; Biver T; Leal JM; Espino G; García B
Inorg Chem; 2013 Sep; 52(17):9962-74. PubMed ID: 23957818
[TBL] [Abstract][Full Text] [Related]
6. New ruthenium(II) arene complexes of anthracenyl-appended diazacycloalkanes: effect of ligand intercalation and hydrophobicity on DNA and protein binding and cleavage and cytotoxicity.
Ganeshpandian M; Loganathan R; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
Dalton Trans; 2014 Jan; 43(3):1203-19. PubMed ID: 24177707
[TBL] [Abstract][Full Text] [Related]
7. The in vitro antitumor activity of arene-ruthenium(II) curcuminoid complexes improves when decreasing curcumin polarity.
Caruso F; Pettinari R; Rossi M; Monti E; Gariboldi MB; Marchetti F; Pettinari C; Caruso A; Ramani MV; Subbaraju GV
J Inorg Biochem; 2016 Sep; 162():44-51. PubMed ID: 27293144
[TBL] [Abstract][Full Text] [Related]
8. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D
J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819
[TBL] [Abstract][Full Text] [Related]
9. A novel dual-functioning ruthenium(II)-arene complex of an anti-microbial ciprofloxacin derivative - Anti-proliferative and anti-microbial activity.
Ude Z; Romero-Canelón I; Twamley B; Fitzgerald Hughes D; Sadler PJ; Marmion CJ
J Inorg Biochem; 2016 Jul; 160():210-7. PubMed ID: 26993079
[TBL] [Abstract][Full Text] [Related]
10. Ruthenium(II) polypyridyl complexes induce BEL-7402 cell apoptosis by ROS-mediated mitochondrial pathway.
Jiang GB; Zheng X; Yao JH; Han BJ; Li W; Wang J; Huang HL; Liu YJ
J Inorg Biochem; 2014 Dec; 141():170-179. PubMed ID: 25268891
[TBL] [Abstract][Full Text] [Related]
11. Comparative solution equilibrium studies of antitumor ruthenium(η
Dömötör O; Pape VFS; May NV; Szakács G; Enyedy ÉA
Dalton Trans; 2017 Mar; 46(13):4382-4396. PubMed ID: 28287667
[TBL] [Abstract][Full Text] [Related]
12. Cellular delivery of pyrenyl-arene ruthenium complexes by a water-soluble arene ruthenium metalla-cage.
Furrer MA; Schmitt F; Wiederkehr M; Juillerat-Jeanneret L; Therrien B
Dalton Trans; 2012 Jun; 41(24):7201-11. PubMed ID: 22506276
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Evaluation of In Vitro DNA/Protein Binding Affinity, Antimicrobial, Antioxidant and Antitumor Activity of Mononuclear Ru(II) Mixed Polypyridyl Complexes.
Putta VR; Chintakuntla N; Mallepally RR; Avudoddi S; K N; Nancherla D; V V N Y; R S P; Surya SS; Sirasani S
J Fluoresc; 2016 Jan; 26(1):225-40. PubMed ID: 26555289
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity, apoptosis, cellular uptake, cell cycle arrest, photocleavage, and antioxidant activity of 1, 10-phenanthroline ruthenium(II) complexes.
Liu YJ; Li ZZ; Liang ZH; Yao JH; Huang HL
DNA Cell Biol; 2011 Oct; 30(10):839-48. PubMed ID: 21568758
[TBL] [Abstract][Full Text] [Related]
15. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.
Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G
Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401
[TBL] [Abstract][Full Text] [Related]
16. Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands.
Zhang Y; Zheng W; Luo Q; Zhao Y; Zhang E; Liu S; Wang F
Dalton Trans; 2015 Aug; 44(29):13100-11. PubMed ID: 26106875
[TBL] [Abstract][Full Text] [Related]
17. Mixed ligand ruthenium(II) complexes of bis(pyrid-2-yl)-/bis(benzimidazol-2-yl)-dithioether and diimines: study of non-covalent DNA binding and cytotoxicity.
Rajendiran V; Murali M; Suresh E; Sinha S; Somasundaram K; Palaniandavar M
Dalton Trans; 2008 Jan; (1):148-63. PubMed ID: 18399241
[TBL] [Abstract][Full Text] [Related]
18. Phenanthroline ligands are biologically more active than their corresponding ruthenium(II) arene complexes.
Valladolid J; Hortigüela C; Busto N; Espino G; Rodríguez AM; Leal JM; Jalón FA; Manzano BR; Carbayo A; García B
Dalton Trans; 2014 Feb; 43(6):2629-45. PubMed ID: 24327227
[TBL] [Abstract][Full Text] [Related]
19. Identification of the structural determinants for anticancer activity of a ruthenium arene peptide conjugate.
Meier SM; Novak M; Kandioller W; Jakupec MA; Arion VB; Metzler-Nolte N; Keppler BK; Hartinger CG
Chemistry; 2013 Jul; 19(28):9297-307. PubMed ID: 23712572
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of DNA/Protein interactions and cytotoxic studies of copper(II) complexes incorporated with N, N donor ligands and terpyridine ligand.
Tummalapalli K; C S V; Munusami P; Pathak M; M M B
Int J Biol Macromol; 2017 Feb; 95():1254-1266. PubMed ID: 27838416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]